2seventy bio, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
ICPT
Intercept Pharmaceuticals, Inc. |
$19.00 | $794.69 M | -17.43 | 341 | $285.71 M |
INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
IOVA
Iovance Biotherapeutics, Inc. |
$7.48 | $2.18 B | -4.3 | 838 | $164.07 M |
KDNY
Chinook Therapeutics, Inc. |
$40.39 | $2.71 B | -12.47 | 214 | $6.13 M |
KZR
Kezar Life Sciences, Inc. |
$6.65 | $49.85 M | -0.49 | 58 | $7.00 M |
MRSN
Mersana Therapeutics, Inc. |
$1.36 | $261.85 M | -1.91 | 102 | $40.50 M |
PBYI
Puma Biotechnology, Inc. |
$3.55 | $170.04 M | 11.02 | 172 | $230.47 M |
PHAT
Phathom Pharmaceuticals, Inc. |
$7.61 | $620.47 M | -2.38 | 427 | $55.25 M |
PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
RCUS
Arcus Biosciences, Inc. |
$14.87 | $1.41 B | -4.98 | 627 | $258.00 M |
REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
RLAY
Relay Therapeutics, Inc. |
$4.57 | $1.05 B | -3 | 261 | $10.01 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
SRPT
Sarepta Therapeutics, Inc. |
$127.89 | $11.66 B | 286.79 | 1372 | $1.90 B |
STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.13 | $754.16 M | -3.26 | 124 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
